Innate pattern-recognition receptors sensing Modified Vaccinia Ankara (MVA-sensing PRRs)

Innate pattern-recognition receptors (PRRs) sensing Modified Vaccinia Ankara (MVA) represent a collective group of immune sensors that detect the attenuated poxvirus to initiate host defense. The primary sensing mechanism involves the cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS), which recognizes MVA genomic DNA and activates the stimulator of interferon genes (STING) pathway, leading to robust type I interferon (IFN) production (Dai et al., 2014). Additionally, MVA is recognized by cell-surface Toll-like receptors, specifically the TLR2-TLR6 heterodimer, which triggers pro-inflammatory cytokine production via the MyD88 adapter (Delaloye et al., 2009). Other sensors, such as MDA5 (sensing viral RNA) and the NLRP3 and AIM2 inflammasomes (sensing DNA and cellular stress), also contribute to the innate immune response (Delaloye et al., 2009). These receptors are critical for the high immunogenicity of MVA-based vaccine vectors, as they bridge innate and adaptive immunity by activating dendritic cells and promoting T-cell responses. Targeting these pathways is a key strategy in developing novel adjuvants and cancer immunotherapies.

Other names

MVA sensorsModified Vaccinia Ankara pattern recognition receptorscGAS-STING pathwayTLR2-TLR6 complexMDA5-MAVS pathwayAIM2 inflammasomeNLRP3 inflammasome

Activation of the cGAS-STING signaling axis, TLR2/TLR6 heterodimers, and MDA5-MAVS pathways to induce interferons and cytokines.